Latest Eversept Partners, LP Stock Portfolio
Eversept Partners, LP Performance:
2024 Q3: 11.27%YTD: 33.11%2023: 3.59%
Performance for 2024 Q3 is 11.27%, and YTD is 33.11%, and 2023 is 3.59%.
About Eversept Partners, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.5 Billions as of 30 Sep, 2024.
The top stock holdings of Eversept Partners, LP are , NTRA, VERA. The fund has invested 11.4% of it's portfolio in GSK PLC and 7.6% of portfolio in NATERA INC.
The fund managers got completely rid off NOVO-NORDISK A S, ELI LILLY & CO (LLY) and SPDR SER TR (BIL) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA), TOURMALINE BIO INC and BIOCRYST PHARMACEUTICALS INC (BCRX). Eversept Partners, LP opened new stock positions in BAUSCH HEALTH COS INC (BHC), FORTREA HLDGS INC and INTRA-CELLULAR THERAPIES INC (ITCI). The fund showed a lot of confidence in some stocks as they added substantially to ZIMVIE INC (ZIMV), KURA ONCOLOGY INC (KURA) and MEREO BIOPHARMA GROUP PLC (MREO).
The top stock holdings of Eversept Partners, LP are , NTRA, VERA. The fund has invested 11.4% of it's portfolio in GSK PLC and 7.6% of portfolio in NATERA INC.
The fund managers got completely rid off NOVO-NORDISK A S, ELI LILLY & CO (LLY) and SPDR SER TR (BIL) stocks. They significantly reduced their stock positions in LIQUIDIA CORPORATION (LQDA), TOURMALINE BIO INC and BIOCRYST PHARMACEUTICALS INC (BCRX). Eversept Partners, LP opened new stock positions in BAUSCH HEALTH COS INC (BHC), FORTREA HLDGS INC and INTRA-CELLULAR THERAPIES INC (ITCI). The fund showed a lot of confidence in some stocks as they added substantially to ZIMVIE INC (ZIMV), KURA ONCOLOGY INC (KURA) and MEREO BIOPHARMA GROUP PLC (MREO).
Eversept Partners, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Eversept Partners, LP made a return of 11.27% in the last quarter. In trailing 12 months, it's portfolio return was 49.09%.
New Buys
| Ticker | $ Bought |
|---|---|
| bausch health cos inc | 12,492,300 |
| fortrea hldgs inc | 9,159,340 |
| intra-cellular therapies inc | 9,109,010 |
| biohaven ltd | 6,622,870 |
| paragon 28 inc | 5,004,740 |
| staar surgical co | 3,388,040 |
| zai lab ltd | 3,264,190 |
| zenas biopharma inc | 3,223,780 |
New stocks bought by Eversept Partners, LP
Additions
| Ticker | % Inc. |
|---|---|
| zimvie inc | 169 |
| kura oncology inc | 166 |
| mereo biopharma group plc | 56.78 |
| avantor inc | 34.27 |
| elevance health inc | 32.8 |
| viatris inc | 29.87 |
| bio-techne corp | 22.2 |
| viridian therapeutics inc | 21.81 |
Additions to existing portfolio by Eversept Partners, LP
Reductions
| Ticker | % Reduced |
|---|---|
| liquidia corporation | -63.07 |
| tourmaline bio inc | -58.8 |
| biocryst pharmaceuticals inc | -53.55 |
| inspire med sys inc | -48.17 |
| united therapeutics corp del | -44.36 |
| brookdale sr living inc | -44.32 |
| molina healthcare inc | -42.07 |
| alector inc | -38.58 |
Eversept Partners, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| seres therapeutics inc | -302,699 |
| oscar health inc | -4,918,330 |
| terns pharmaceuticals inc | -1,949,470 |
| g1 therapeutics inc | -455,916 |
| myriad genetics inc | -4,450,770 |
| fulcrum therapeutics inc | -948,383 |
| novo-nordisk a s | -20,976,500 |
| viking therapeutics inc | -7,341,300 |
Eversept Partners, LP got rid off the above stocks
Sector Distribution
Eversept Partners, LP has about 80.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 80.2 |
| Others | 19.5 |
Market Cap. Distribution
Eversept Partners, LP has about 36.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 36.6 |
| MID-CAP | 21.7 |
| UNALLOCATED | 20.3 |
| SMALL-CAP | 19.2 |
| MICRO-CAP | 2.2 |
Stocks belong to which Index?
About 52.5% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 47.5 |
| RUSSELL 2000 | 39.2 |
| S&P 500 | 13.3 |
Eversept Partners, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Eversept Partners, LP
Eversept Partners, LP has 65 stocks in it's portfolio. About 55.4% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. INSP was the most profitable stock for Eversept Partners, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.07 | 272,869 | 1,042,360 | reduced | -16.17 | ||
| ALEC | alector inc | 0.11 | 332,756 | 1,550,640 | reduced | -38.58 | ||
| AMRN | amarin corp plc | 0.14 | 3,309,310 | 2,074,610 | reduced | -23.19 | ||
| ARQT | arcutis biotherapeutics inc | 0.44 | 693,263 | 6,447,350 | reduced | -17.26 | ||
| AUTL | autolus therapeutics plc | 0.10 | 406,558 | 1,475,810 | reduced | -33.45 | ||
| AVTE | aerovate therapeutics inc | 0.07 | 485,141 | 1,013,940 | new | |||
| AVTR | avantor inc | 0.30 | 168,369 | 4,355,710 | added | 34.27 | ||
| BCRX | biocryst pharmaceuticals inc | 0.28 | 535,405 | 4,069,080 | reduced | -53.55 | ||
| BHC | bausch health cos inc | 0.86 | 1,530,910 | 12,492,300 | new | |||
| BIL | spdr ser tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BKD | brookdale sr living inc | 0.40 | 861,268 | 5,848,010 | reduced | -44.32 | ||
| CERE | cerevel therapeutics hldng i | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 1.31 | 564,902 | 19,201,000 | reduced | -10.76 | ||
| CNC | centene corp del | 0.70 | 134,959 | 10,159,700 | added | 16.52 | ||
| CYH | community health sys inc new | 3.65 | 8,776,460 | 53,273,100 | added | 9.19 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DHR | danaher corporation | 0.73 | 38,429 | 10,684,000 | reduced | -5.94 | ||
| ELV | elevance health inc | 0.69 | 19,465 | 10,121,800 | added | 32.8 | ||
| EOLS | evolus inc | 0.50 | 453,061 | 7,339,590 | reduced | -21.13 | ||
| FNA | paragon 28 inc | 0.34 | 749,213 | 5,004,740 | new | |||